2017
DOI: 10.1186/s12936-017-2104-5
|View full text |Cite
|
Sign up to set email alerts
|

Expanding malaria diagnosis and treatment in Lao PDR: lessons learned from a public–private mix initiative

Abstract: BackgroundAs in other countries of the Greater Mekong Sub-region (GMS), the private health sector constitutes a significant avenue where malaria services are provided and presents a unique opportunity for public–private collaboration. In September 2008, a public–private mix (PPM) strategy was launched initially in four northern and southern provinces in Lao PDR to increase access to rapid diagnostic tests (RDTs) and artemisinin-based combination therapy (ACT), improve quality of care, and collect routine malar… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
27
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 21 publications
(30 citation statements)
references
References 7 publications
1
27
0
Order By: Relevance
“…The present study has some limitations. First, because the survey period did not coincide with the high transmission season (often between June and August) [21], the present study could underestimate the prevalence of malaria infection. Second, the participation rate was 75.4%, suggesting that there is a possibility of selection bias.…”
Section: Discussionmentioning
confidence: 99%
“…The present study has some limitations. First, because the survey period did not coincide with the high transmission season (often between June and August) [21], the present study could underestimate the prevalence of malaria infection. Second, the participation rate was 75.4%, suggesting that there is a possibility of selection bias.…”
Section: Discussionmentioning
confidence: 99%
“…education, agriculture, environment). The experience in Laos suggests extending diagnosis and treatment coverage to all febrile patients in endemic areas while leveraging support from the private sector [ 13 ]. Although this study did not assess asymptomatic patients or submicroscopic malaria, they are acknowledged as a challenge and a critical reservoir that is sustaining malaria transmission, as pointed out by Stresman et al [ 14 ].…”
Section: Discussionmentioning
confidence: 99%
“…Artemether–lumefantrine, one of the artemisinin-based combinations, has been used in Laos as the first-line treatment regimen for P. falciparum since 2005 and for P. vivax since 2011 [17]. Through the support of the Global Fund, the ACT is prescribed to malaria patients free of charge at public healthcare facilities, and some private clinics and pharmacies after a confirmation of Plasmodium infection by microscopy or RDTs, which is termed “Private–Public Mix programme” [18]. Therefore, currently, the ACT is not available without proper diagnosis.…”
Section: Discussionmentioning
confidence: 99%